Verona Pharma Plc Adr (VRNA)

Jan 21, 2025

Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight - GlobeNewswire Inc.

Jan 21, 2025

Jan 17, 2025

Looking For A Top Momentum Pick? Why Valley National Bancorp (NASDAQ: VLY) Is A Great Choice - Stocks Register

Jan 17, 2025

Jan 17, 2025

Hertz Global Holdings Inc (NASDAQ: HTZ): Overvalued Compared To Others? - Stocks Register

Jan 17, 2025

Jan 17, 2025

Verona Pharma Plc ADR (VRNA) Outlook: Looking Back For Insights - Stocks Register

Jan 17, 2025

Jan 16, 2025

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week - Yahoo! Voices

Jan 16, 2025

Jan 08, 2025

Verona Pharma stock target increased, keeps buy on Q4 sales By Investing.com - Investing.com South Africa

Jan 08, 2025

Jan 07, 2025

Verona Pharma stock soars to all-time high of $49.05 - Investing.com India

Jan 07, 2025

Dec 29, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Dec 29, 2024

Dec 23, 2024

Verona Pharma stock soars to all-time high of $43.76 - Investing.com

Dec 23, 2024

Dec 07, 2024

Verona Pharma CFO Mark Hahn sells shares worth $4.4 million - Investing.com India

Dec 07, 2024

Dec 06, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $4.36 million - Investing.com

Dec 06, 2024

Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 - Investing.com India

Dec 02, 2024

Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 By Investing.com - Investing.com South Africa

Dec 02, 2024

Dec 02, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $627,233 - Investing.com

Dec 02, 2024

Nov 27, 2024

Verona Pharma CFO sells shares totaling $12,000 - Investing.com India

Nov 27, 2024

Nov 27, 2024

Verona Pharma's chief medical officer sells $1.18 million in shares - Investing.com India

Nov 27, 2024

Nov 26, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $8,000 - Investing.com

Nov 26, 2024

Nov 18, 2024

Verona Pharma director David Ebsworth buys $88,800 in shares - Investing.com India

Nov 18, 2024

Nov 07, 2024

Verona Pharma director Christina Ackermann acquires $198,385 in shares - Investing.com

Nov 07, 2024

Nov 05, 2024

Verona Pharma CFO Mark Hahn sells shares worth $568,386 - Investing.com

Nov 05, 2024

Nov 05, 2024

Verona Pharma CEO David Zaccardelli sells $618,657 in shares - Investing.com

Nov 05, 2024

Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com Nigeria

Nov 04, 2024

Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com India

Nov 04, 2024

Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria

Nov 04, 2024

Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa

Nov 04, 2024

Nov 04, 2024

Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Nov 04, 2024

Oct 25, 2024

Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India

Oct 25, 2024

Oct 25, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India

Oct 25, 2024

Oct 25, 2024

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart

Oct 25, 2024

Oct 24, 2024

5 Biotech Stocks Likely To Outperform As Industry Prospects Look Bright - Barchart

Oct 24, 2024

Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India

Oct 22, 2024

Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa

Oct 22, 2024

Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa

Oct 22, 2024

Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India

Oct 22, 2024

Oct 21, 2024

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Yahoo Finance

Oct 21, 2024

Oct 16, 2024

Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex

Oct 16, 2024

Oct 15, 2024

Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily

Oct 15, 2024

Oct 15, 2024

Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024

Oct 15, 2024

Verona Pharma Plc ADR (VRNA) stock: A year of ups and downs - US Post News

Oct 15, 2024

Oct 11, 2024

VRNA Shares Experience Decline in Value - Knox Daily

Oct 11, 2024

Oct 09, 2024

Financial Metrics Exploration: Understanding Verona Pharma Plc ADR (VRNA) Through Ratios - The Dwinnex

Oct 09, 2024

Oct 09, 2024

A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News

Oct 09, 2024

Oct 09, 2024

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Oct 09, 2024

Oct 08, 2024

Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily

Oct 08, 2024

Oct 08, 2024

Verona Pharma Plc ADR’s (NASDAQ: VRNA) Stock Forecast: Increase To $38 In A Year - Stocks Register

Oct 08, 2024

Oct 07, 2024

Prepare Yourself for Liftoff: Verona Pharma Plc ADR (VRNA) - SETE News

Oct 07, 2024

Oct 04, 2024

Verona Pharma Plc ADR [VRNA] stock for 2,254,320 USD was sold by ZACCARDELLI DAVID - Knox Daily

Oct 04, 2024

Oct 04, 2024

Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 04, 2024

Oct 04, 2024

Cactus Inc [WHD] Records 50-Day SMA of $59.34 - Knox Daily

Oct 04, 2024

Oct 03, 2024

Verona Pharma stock soars to all-time high of $30.76 By Investing.com - Investing.com South Africa

Oct 03, 2024

Oct 03, 2024

Piper Sandler maintains Overweight rating on Verona Pharma shares By Investing.com - Investing.com South Africa

Oct 03, 2024